Press Release: P3 Health Partners Announces Third Quarter 2026 Results

Dow Jones11-10

Adjusted EBITDA of $21 Million for the Third Quarter and $101 Million Year-to-Date

Raises Full-Year 2026 Adjusted EBITDA Guidance Midpoint

Management to Host Conference Call and Webcast November 9, 2026 at 4:30 PM ET

HENDERSON, Nev.--(BUSINESS WIRE)--November 09, 2026-- 

P3 Health Partners Inc. ("P3" or the "Company") $(PIII)$, a patient-centered and physician-led population health management company, today announced its financial results for the third quarter ended September 30, 2026.

"This was another strong quarter for P3. The foundation we have built over the past two years is showing up both in the care our patients receive and in the consistency of our results. We carry real momentum into 2027, as evidenced by our medical cost trend, and I am excited about what lies ahead for our patients, our providers, and our partners, " said Dr. Aric Coffman, CEO of P3.

Third Quarter 2026 Financial Results

   --  At-risk membership was approximately 105,000 members for the third 
      quarter, a decrease of 9% compared to prior year, reflecting previously 
      disclosed intentional network and payer rationalization. Total lives 
      under management were approximately 133,500 for the quarter, including 
      the approximately 28,000 lives under management service arrangements. 
 
   --  Total revenue was $396 million, an increase of 15% compared with the 
      prior year quarter. Total per-member capitated revenue increased 18% from 
      the same period in the prior year driven by improved network economics, 
      rate progression, and burden of illness performance. 
 
   --  Medical margin(1) for the quarter was $43.9 million, or $140 on a 
      per-member-per-month basis. The results include the favorable impact of 
      payer settlements and prior year development recognized in the quarter. 
      Excluding these items, medical margin for the quarter was $35.0 million, 
      or $111 on a per-member-per-month basis. 
 
   --  Net income was $30.8 million compared to net loss of $69.5 million in 
      the prior year quarter. 
 
   --  Adjusted EBITDA(1) for the quarter was $20.9 million, or $66 PMPM, 
      compared to a loss of $45.9 million, or negative $132 
      per-member-per-month in the prior year quarter. 

Revised Fiscal 2026 Guidance

   --  Full-year revised guidance reflects the increase to the low end of the 
      Adjusted EBITDA range to $90 million, raising the midpoint to $100 
      million, based on underlying year-to-date performance, as well as the 
      prior-year development and payer settlements recognized in the quarter. 
 
 
                                              Year Ending December 31, 2026 
                                             ------------------------------- 
                                                   Low             High 
                                             ---------------  -------------- 
At-risk Members(2)                               102,000         106,000 
Total Revenues (in millions)                     $1,525           $1,600 
Medical Margin(1)(3) (in millions)                $260             $300 
Medical Margin(1)(3) PMPM                         $210             $240 
Adjusted EBITDA(1)(3) (in millions)                $90             $110 
(1) Adjusted EBITDA, Adjusted EBITDA per member, per month ("PMPM"), medical 
margin, and medical margin PMPM are non-GAAP financial measures. For 
reconciliations of these measures to the most directly comparable GAAP 
measures, if applicable, and more information regarding the Company's use of 
non-GAAP financial measures, please see the section titled "Non-GAAP 
Financial Measures." 
(2) See "Key Performance Metrics" for additional information on how the 
Company defines "at-risk members." 
(3) The Company is not able to provide a quantitative reconciliation of 
guidance for Adjusted EBITDA, medical margin and medical margin PMPM to net 
income (loss), gross profit and gross profit PMPM, the most directly 
comparable GAAP measures, respectively, and has not provided forward-looking 
guidance for net income (loss), because of the uncertainty around certain 
items that may impact net income (loss), gross profit (loss) or gross profit 
(loss) PMPM that are not within our control or cannot be reasonably 
predicted without unreasonable effort. For more information regarding the 
non-GAAP financial measures discussed in this press release, please see 
"Non-GAAP Financial Measures" below. 
 

The foregoing 2026 outlook statement represents management's current estimate as of the date of this release. Actual results may differ materially depending on a number of factors. Investors are urged to read the "Cautionary Note Regarding Forward-Looking Statements" included in this release. Management does not assume any obligation to update these estimates.

Management to Host Conference Call and Webcast on November 9, 2026 at 4:30 PM ET

 
 Title & Webcast            P3 Health Third Quarter 2026 Earnings Conference 
                            Call 
-------------------------  --------------------------------------------------- 
 Date & Time                November 9, 2026, 4:30 PM Eastern Time 
-------------------------  --------------------------------------------------- 
 Conference Call Details    Toll-Free 1-833-316-0546 (US) 
                             International 1-412-317-0692 
                             Ask to be joined into the P3 Health Partners call 
-------------------------  --------------------------------------------------- 
 The conference call will also be webcast live in the "Events & Presentations" 
 section of the Investor page of the P3 website (ir.p3hp.org). The Company's 
 press release will be available on the Investor page of P3's website in 
 advance of the conference call. An archived recording of the webcast will be 
 available on the Investor page of P3's website for a period of 90 days 
 following the conference call. 
------------------------------------------------------------------------------ 
 

About P3 Health Partners (NASDAQ: PIII):

P3 Health Partners Inc. is a leading population health management company committed to transforming healthcare by improving the lives of both patients and providers. Founded and led by physicians, P3 has an expansive network of more than 2,000 affiliated primary care providers across the country. Our local teams of health care professionals manage the care of thousands of patients in 26 counties across five states. P3 supports primary care providers with value-based care coordination and administrative services that improve patient outcomes and lower costs. Through partnerships with these local providers, the P3 care team creates an enhanced patient experience by navigating, coordinating, and integrating the patient's care within the healthcare system. For more information, visit www.p3hp.org and follow us on LinkedIn and Facebook.com/p3healthpartners.

Non-GAAP Financial Measures

In addition to the financial results prepared in accordance with accounting principles generally accepted in the U.S. ("GAAP"), this press release contains certain non-GAAP financial measures as defined by the SEC rules, including Adjusted EBITDA and Adjusted EBITDA PMPM, medical margin, medical margin PMPM, and adjusted operating expense. EBITDA is defined as GAAP net income (loss) before (i) interest, (ii) income taxes and (iii) depreciation and amortization. Adjusted EBITDA is defined as EBITDA, further adjusted to exclude the effect of certain supplemental adjustments, such as (i) mark-to-market warrant gain/loss, (ii) premium deficiency reserves, (iii) equity-based compensation expense, (iv) certain transaction and other related costs and (v) certain other items that we believe are not indicative of our core operating performance. Adjusted EBITDA PMPM is defined as Adjusted EBITDA divided by the number of at-risk Medicare members each month divided by the number of months in the period. We believe these non--GAAP financial measures provide an additional tool for investors to use in evaluating ongoing operating results and trends and in comparing our financial measures with other similar companies. Medical margin represents the amount earned from capitation revenue after medical claims expenses are deducted and medical margin PMPM is defined as medical margin divided by the number of Medicare members each month divided by the number of months in the period. Medical claims expenses represent costs incurred for medical services provided to our members. As our platform grows and matures over time, we expect medical margin to increase in absolute dollars; however, medical margin PMPM may vary as the percentage of new members brought onto our platform fluctuates. New membership added to the platform is typically dilutive to medical margin PMPM. Adjusted operating expense is defined as total operating expense excluding depreciation and amortization and costs that management believes are non-core to the underlying operations of the Company, consisting of (i) medical expense, (ii) premium deficiency reserves, (iii) equity-based compensation, and (iv) certain other items that we believe are not indicative of our core operating performance. We do not consider these non--GAAP measures in isolation or as an alternative to financial measures determined in accordance with GAAP. These non-GAAP financial measures are subject to inherent limitations as they reflect the exercise of judgments by management about which expense and income are excluded or included in determining these non--GAAP financial measures. In addition, other companies may calculate non-GAAP financial measures differently or may use other measures to evaluate their performance, all of which could reduce the usefulness of our non-GAAP financial measures as tools for comparison. The tables at the end of this press release present a reconciliation of Adjusted EBITDA, medical margin to gross profit, medical margin PMPM to gross profit PMPM, and adjusted operating expense to operating expense, which are the most directly

comparable financial measures calculated in accordance with GAAP.

Key Performance Metrics

In addition to our GAAP and non-GAAP financial information, the Company also monitors "at-risk members" to help us evaluate our business, identify trends affecting our business, formulate business plans and make strategic decisions. At-risk membership represents the approximate number of Medicare members for whom we receive a fixed percentage of premium under capitation arrangements as of the end of a particular period.

Cautionary Note Regarding Forward-Looking Statements

This press release contains forward-looking statements within the meaning of the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995. We intend such forward-looking statements to be covered by the safe harbor provisions for forward-looking statements contained in Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Words such as "anticipate," "believe," "budget," "contemplate," "continue," "could," "envision," "estimate," "expect," "guidance," "indicate," "intend," "may," "might," "plan," "possibly," "potential," "predict," "probably," "pro-forma," "project," "seek," "should," "target, " or "will," or the negative or other variations thereof, and similar words or phrases or comparable terminology, are intended to identify forward-looking statements. These forward-looking statements address various matters, including the Company's future expected growth strategy and operating performance; and the Company's ability to execute on its identified strategic improvement opportunities, all of which reflect the Company's expectations based upon currently available information and data. Because such statements are based on expectations as to future financial and operating results and are not statements of fact, actual results may differ materially from those projected or estimated and you are cautioned not to place undue reliance on these forward-looking statements. These forward-looking statements are not guarantees of future performance, conditions or results, and involve a number of known and unknown risks, uncertainties, assumptions and other important factors, many of which are outside the Company's control, that could cause actual results or outcomes to differ materially from those discussed in the forward-looking statements.

Important risks and uncertainties that could cause our actual results and financial condition to differ materially from those indicated in forward-looking statements include, among others, our ability to continue as a going concern; our potential need to raise additional capital to fund our existing operations or develop and commercialize new services or expand our operations; our ability to achieve or maintain profitability; our ability to maintain compliance with our debt covenants in the future, or obtain required waivers from our lenders if future operating performance were to fall below current projections, and if there are material changes to management's assumptions, we could be required to recognize non-cash charges to operating earnings for goodwill and/or other intangible asset impairment; our ability to identify and develop successful new geographies, physician partners, payors and patients; changes in market or industry conditions, regulatory environment, competitive conditions, and receptivity to our services; our ability to fund our growth and expand our operations; changes in laws and regulations applicable to our business; our ability to maintain our relationships with health plans and other key payors; the impact of fluctuations in risk adjustments; our ability to establish and maintain effective internal controls; our ability to maintain compliance with California regulations related to financial solvency and operational performance; our ability to maintain the listing of our securities on Nasdaq; increased labor costs and medical expense; our ability to recruit and retain qualified team members and independent physicians; and the factors described under Part I, Item 1A. "Risk Factors" and Part II, Item 7. "Management's Discussion and Analysis of Financial Condition and Results of Operations" in our Annual Report on Form 10-K for the year ended December 31, 2025, filed with the SEC on March 26, 2026, and in our subsequent filings with the SEC.

All information in this press release is as of the date hereof, and we undertake no duty to update or revise this information unless required by law. You are cautioned not to place undue reliance on any forward-looking statements contained in this press release.

 
                 P3 HEALTH PARTNERS INC. and SUBSIDIARIES 
                  CONDENSED CONSOLIDATED BALANCE SHEETS 
                 (in thousands, except per share amounts) 
                               (unaudited) 
 
                                September 30, 2026     December 31, 2025 
                               --------------------  --------------------- 
ASSETS 
CURRENT ASSETS: 
   Cash                         $           43,900    $          25,012 
   Restricted cash                           1,902                  795 
   Health plan receivable, 
    net of allowance for 
    credit losses of $1,556 
    and $281 as of September 
    30, 2026 and December 31, 
    2025, respectively                     134,384               92,458 
   Clinic fees, insurance and 
    other receivable                        20,102                3,379 
   Prepaid expenses and other 
    current assets                          15,739               11,439 
                                   ---------------       -------------- 
TOTAL CURRENT ASSETS                       216,027              133,083 
Property and equipment, net                  2,145                3,374 
Intangible assets, net                     431,821              492,423 
Other long-term assets                      19,726               27,761 
                                   ---------------       -------------- 
TOTAL ASSETS                    $          669,719    $         656,641 
                                   ===============       ============== 
LIABILITIES, MEZZANINE 
EQUITY, AND STOCKHOLDERS' 
(DEFICIT) EQUITY 
----------------------------- 
CURRENT LIABILITIES: 
   Accounts payable             $            7,695    $          11,715 
   Accrued expenses and other 
    current liabilities                     40,639               42,820 
   Accrued payroll                           3,470                1,950 
   Health plan settlements 
    payable                                  4,119               69,830 
   Claims payable                          221,401              287,790 
   Premium deficiency reserve               44,792               86,116 
   Current portion of 
    long-term debt                          84,428               45,036 
   Short-term debt                             104                   -- 
                                   ---------------       -------------- 
TOTAL CURRENT LIABILITIES                  406,648              545,257 
Operating lease liability, 
 net                                         9,994               11,475 
Warrant liabilities                          5,723                2,462 
Long-term debt, net                         37,331              228,374 
Other long-term liabilities                  9,308                9,308 
                                   ---------------       -------------- 
TOTAL LIABILITIES                          469,004              796,876 
                                   ---------------       -------------- 
COMMITMENTS AND CONTINGENCIES 
MEZZANINE EQUITY: 
   Redeemable non-controlling 
    interest                                90,256               14,997 
STOCKHOLDERS' EQUITY 
(DEFICIT): 
   Series A 13.5% Cumulative 
   Preferred Stock                          21,186                   -- 
   Series B 17.5% Cumulative 
   Preferred Stock                          18,717                   -- 
   Series C 19.5% Cumulative 
   Preferred Stock                          81,317                   -- 
   Series D 19.5% Cumulative 
   Preferred Stock                          54,748                   -- 
   Series D-1 19.5% 
   Cumulative Preferred 
   Stock                                     9,274                   -- 
   Class A common stock                         --                   -- 
   Class V common stock                         --                   -- 
   Additional paid in capital              548,885              495,909 
   Accumulated deficit                    (626,853)            (651,141) 
   Non-controlling interest                  3,185                   -- 
                                   ---------------       -------------- 
TOTAL STOCKHOLDERS' EQUITY 
 (DEFICIT)                                 110,459             (155,232) 
                                   ---------------       -------------- 
TOTAL LIABILITIES, MEZZANINE 
 EQUITY, AND STOCKHOLDERS' 
 EQUITY (DEFICIT)               $          669,719    $         656,641 
                                   ===============       ============== 
 
 
              P3 HEALTH PARTNERS INC. and SUBSIDIARIES 
          CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS 
              (in thousands, except per share amounts) 
                            (unaudited) 
 
                     Three Months Ended       Nine Months Ended 
                       September 30,            September 30, 
                    --------------------  -------------------------- 
                      2026       2025        2026         2025 
OPERATING REVENUE: 
   Capitated 
    revenue         $366,291   $341,555   $1,112,188   $1,062,796 
   Other revenue      30,053      3,698       56,927       11,470 
                     -------    -------    ---------    --------- 
TOTAL OPERATING 
 REVENUE             396,344    345,253    1,169,115    1,074,266 
OPERATING EXPENSE: 
   Medical expense   346,001    369,789      982,402    1,093,182 
   Premium 
    deficiency 

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment